Article info
Ovarian Cancer
Multicenter Phase 2 Study of Combined Gemcitabine and Epirubicin as Second-Line Treatment for Patients With Advanced Ovarian Cancer
- Address correspondence and reprint requests to Viviana Murgia, MD, Department of Medical Oncology, Santa Chiara Hospital, Largo Medaglie d'Oro, 38100, Trento, Italy. E-mail: viviana.murgia{at}apss.tn.it.
Citation
Multicenter Phase 2 Study of Combined Gemcitabine and Epirubicin as Second-Line Treatment for Patients With Advanced Ovarian Cancer
Publication history
- Received February 17, 2010
- First published July 1, 2010.
Online issue publication
June 17, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright © 2010 by IGCS and ESGO